Rabeprazol Sandoz 20 mg, magensaftresistente Tabletten - 14 Tablette(n) Swissmedic Key 61496004 Registration Holder Sandoz Pharmaceuticals AG Name Rabeprazol Sandoz 20 mg, magensaftresistente Tabletten Date of registration 13.05.2011 Original/Generic Generic Introduction of Sequence 13.05.2011 ATC-Classification Rabeprazole (A02BC04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 04.99. Show package size 14 Tablette(n) Index Therapeuticus (Swissmedic) 04.99. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 9.01 Limitation No Deductible 10 % Consumer price 26.20 Feedback FB Daily cost GTIN 7680614960049 Medication Code Synthetika Pharmacode 5404363 Disponibility
Composition rabeprazolum natricum 20 mg corresp. rabeprazolum 18.85 mg, calcii hydroxidum, mannitolum, hydroxypropylcellulosum substitutum humile, natrii stearylis fumaras, Überzug: hypromellosum, talcum, hypromellosi phthalas, dibutylis sebacas, E 171, E 172 (flavum) pro compresso obducto corresp. natrium 1.42 mg. Packungsbestandteile Galenic Form Gastric juice resistant tablets Active Agent Dose Rabeprazole Sodium 20 mg correspond Rabeprazole 18.85 mg
BAG: Active Agent Dose Rabeprazole Sodium 20 mg
Inactive agents additional_information (Flavum) pro Compresso Obducto Calcium Hydroxide Dibutylis Sebacas E 171 color. E 172 color. Hydroxypropylcellulosum Substitutum Humile Hypromellosi Phthalas Hypromellosum Überzug Mannitol Natrii Stearylis Fumaras Talcum
Source Data was imported : 12.05.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
